Quick Answer
Arcadia Biosciences, Inc. reported Net Income Loss of -$2.34 million for the year ending 2025.
- Arcadia Biosciences, Inc. showed an increase of +66.8% in Net Income Loss from 2024 to 2025.
- This data is from Arcadia Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 12 years of available data (2014 to 2025), Arcadia Biosciences, Inc.'s Net Income Loss has grown by 87.2%.
- Historical annual values: Fiscal year 2025: -$2.34 million | Fiscal year 2024: -$7.04 million | Fiscal year 2023: -$13.98 million | Fiscal year 2022: -$15.38 million | Fiscal year 2021: -$14.66 million | Fiscal year 2020: -$4.66 million | Fiscal year 2019: -$28.81 million | Fiscal year 2018: -$13.48 million | Fiscal year 2017: -$15.71 million | Fiscal year 2016: -$19.62 million | Fiscal year 2015: -$17.96 million | Fiscal year 2014: -$18.34 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: